Cara Therapeutics | CARA - Revenu Net





Revenu Net Changement Date
Acadia Pharmaceuticals USD 3.64M 269.93M 2026-03
Alterity Therapeutics Limited AUD -6.3M 525.41K 2025-12
Assertio Holdings USD -2.92M 753K 2024-09
Cara Therapeutics USD -5.53M 621K 2025-09
Cassava Sciences USD -12.54M 1.73M 2025-12
Chugai Pharma JPY 115.42B 12.99B 2026-03
Cipla INR 5.55B 1.21B 2026-03
Clal Biotechnology ILS -6.17M 15.56M 2022-12
Compugen USD 56.84M 63.82M 2025-12
CSL USD 401M 96.5M 2025-12
Grifols EUR 114.37M 34.03M 2025-12
Halozyme Therapeutics USD 150.05M 291.64M 2026-03
J&J USD 5.24B 119M 2026-03
Neurocrine Biosciences USD 197.9M 44.2M 2026-03
Pacira USD 2.92M 1.28M 2026-03
Pfizer USD 2.69B 4.34B 2026-03
RedHill Biopharma USD -1.54M 0 2024-06
Supernus Pharmaceuticals USD -2.29M 1.81M 2026-03
Vanda Pharmaceuticals USD -18.9M 13.58M 2024-12